Whitepapers

Jan 6, 2026
2025 in Review
From unprecedented US drug pricing reforms to the launch of Europe’s new HTA regulation, 2025 reshaped the rules of market access worldwide. We explored how early planning, stronger evidence generation, and deeper cross-functional collaboration are now essential to success. Discover our key insights and the practical steps you can take today to stay ahead in 2026.